Annual CFF
$6.53 M
+$5.35 M+454.41%
31 December 2023
Summary:
Fresh Tracks Therapeutics annual cash flow from financing activities is currently $6.53 million, with the most recent change of +$5.35 million (+454.41%) on 31 December 2023. During the last 3 years, it has fallen by -$26.42 million (-80.18%). FRTX annual CFF is now -94.56% below its all-time high of $120.00 million, reached on 01 December 2000.FRTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$28.00 K
-$18.00 K-180.00%
31 December 2023
Summary:
Fresh Tracks Therapeutics quarterly cash flow from financing activities is currently -$28.00 thousand, with the most recent change of -$18.00 thousand (-180.00%) on 31 December 2023. FRTX quarterly CFF is now -100.02% below its all-time high of $119.60 million, reached on 01 March 2000.FRTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$6.53 M
-$36.00 K-0.55%
31 December 2023
Summary:
Fresh Tracks Therapeutics TTM cash flow from financing activities is currently $6.53 million, with the most recent change of -$36.00 thousand (-0.55%) on 31 December 2023. FRTX TTM CFF is now -94.56% below its all-time high of $120.00 million, reached on 01 December 2000.FRTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FRTX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -80.2% | -100.3% | -80.2% |
| 5 y5 years | +147.8% | -159.6% | +147.8% |
FRTX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -80.2% | +454.4% | -100.3% | +49.1% | -80.2% | +454.4% |
| 5 y | 5 years | -83.0% | +454.4% | -100.2% | +49.1% | -86.1% | +454.4% |
| alltime | all time | -94.6% | +336.4% | -100.0% | +99.2% | -94.6% | +207.9% |
Fresh Tracks Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $6.53 M(+454.4%) | -$28.00 K(+180.0%) | $6.53 M(-0.5%) |
| Sept 2023 | - | -$10.00 K(<-9900.0%) | $6.57 M(-14.1%) |
| June 2023 | - | $0.00(-100.0%) | $7.64 M(-2.1%) |
| Mar 2023 | - | $6.57 M(>+9900.0%) | $7.80 M(+562.3%) |
| Dec 2022 | $1.18 M(-96.4%) | $8000.00(-99.2%) | $1.18 M(-89.7%) |
| Sept 2022 | - | $1.06 M(+565.6%) | $11.47 M(-38.1%) |
| June 2022 | - | $160.00 K(-390.9%) | $18.52 M(-16.9%) |
| Mar 2022 | - | -$55.00 K(-100.5%) | $22.30 M(-32.3%) |
| Dec 2021 | $32.95 M(-14.3%) | - | - |
| Dec 2021 | - | $10.30 M(+26.8%) | $32.95 M(-11.8%) |
| Sept 2021 | - | $8.12 M(+106.2%) | $37.37 M(+17.3%) |
| June 2021 | - | $3.94 M(-62.8%) | $31.85 M(-32.3%) |
| Mar 2021 | - | $10.60 M(-28.0%) | $47.03 M(+22.4%) |
| Dec 2020 | $38.44 M(+1358.3%) | $14.71 M(+466.6%) | $38.44 M(+61.7%) |
| Sept 2020 | - | $2.60 M(-86.4%) | $23.77 M(+0.1%) |
| June 2020 | - | $19.12 M(+853.8%) | $23.75 M(+476.3%) |
| Mar 2020 | - | $2.00 M(+4166.0%) | $4.12 M(+56.3%) |
| Dec 2019 | $2.64 M(>+9900.0%) | $47.00 K(-98.2%) | $2.64 M(+1.8%) |
| Sept 2019 | - | $2.58 M(-608.1%) | $2.59 M(>+9900.0%) |
| June 2019 | - | -$507.00 K(-197.5%) | $13.00 K(-97.5%) |
| Mar 2019 | - | $520.00 K(>+9900.0%) | $519.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2018 | - | $0.00(-100.0%) | $29.43 M(-2.7%) |
| June 2018 | - | -$1000.00(-200.0%) | $30.23 M(-1.0%) |
| Mar 2018 | - | $1000.00(-100.0%) | $30.54 M(-0.0%) |
| Dec 2017 | $30.55 M(+294.4%) | $29.43 M(+3565.3%) | $30.55 M(+2649.3%) |
| Sept 2017 | - | $803.00 K(+161.6%) | $1.11 M(-86.2%) |
| June 2017 | - | $307.00 K(>+9900.0%) | $8.06 M(+4.0%) |
| Mar 2017 | - | $3000.00(-250.0%) | $7.75 M(+0.1%) |
| Dec 2016 | $7.74 M(<-9900.0%) | -$2000.00(-100.0%) | $7.74 M(-0.0%) |
| Sept 2016 | - | $7.75 M(<-9900.0%) | $7.75 M(<-9900.0%) |
| June 2016 | - | -$3000.00(+50.0%) | -$7000.00(-12.5%) |
| Mar 2016 | - | -$2000.00(<-9900.0%) | -$8000.00(-60.0%) |
| Dec 2015 | -$20.00 K(-100.5%) | $0.00(-100.0%) | -$20.00 K(-115.6%) |
| Sept 2015 | - | -$2000.00(-50.0%) | $128.00 K(-95.4%) |
| June 2015 | - | -$4000.00(-71.4%) | $2.78 M(-28.4%) |
| Mar 2015 | - | -$14.00 K(-109.5%) | $3.88 M(+0.4%) |
| Dec 2014 | $3.87 M(+1057.5%) | $148.00 K(-94.4%) | $3.87 M(+4.3%) |
| Sept 2014 | - | $2.65 M(+140.9%) | $3.71 M(+160.1%) |
| June 2014 | - | $1.10 M(-3889.7%) | $1.43 M(+1681.3%) |
| Mar 2014 | - | -$29.00 K(+163.6%) | $80.00 K(-76.0%) |
| Dec 2013 | $334.00 K(-99.3%) | -$11.00 K(-103.0%) | $334.00 K(+13.2%) |
| Sept 2013 | - | $366.00 K(-248.8%) | $295.00 K(+656.4%) |
| June 2013 | - | -$246.00 K(-209.3%) | $39.00 K(-84.0%) |
| Mar 2013 | - | $225.00 K(-550.0%) | $244.00 K(-99.5%) |
| Dec 2012 | $48.68 M(>+9900.0%) | -$50.00 K(-145.5%) | $48.68 M(-0.2%) |
| Sept 2012 | - | $110.00 K(-368.3%) | $48.79 M(+0.1%) |
| June 2012 | - | -$41.00 K(-100.1%) | $48.75 M(-0.1%) |
| Mar 2012 | - | $48.66 M(>+9900.0%) | $48.78 M(>+9900.0%) |
| Dec 2011 | $55.00 K(-99.9%) | $59.00 K(-11.9%) | $55.00 K(-93.3%) |
| Sept 2011 | - | $67.00 K(-937.5%) | $825.00 K(-97.4%) |
| June 2011 | - | -$8000.00(-87.3%) | $32.23 M(+0.0%) |
| Mar 2011 | - | -$63.00 K(-107.6%) | $32.23 M(-13.3%) |
| Dec 2010 | $37.17 M(+13.2%) | $829.00 K(-97.4%) | $37.17 M(-8.3%) |
| Sept 2010 | - | $31.47 M(<-9900.0%) | $40.53 M(+113.6%) |
| June 2010 | - | -$14.00 K(-100.3%) | $18.97 M(-49.8%) |
| Mar 2010 | - | $4.88 M(+16.5%) | $37.81 M(+15.1%) |
| Dec 2009 | $32.84 M(+878.1%) | $4.19 M(-57.8%) | $32.84 M(+15.1%) |
| Sept 2009 | - | $9.92 M(-47.3%) | $28.55 M(+54.2%) |
| June 2009 | - | $18.82 M(<-9900.0%) | $18.51 M(+426.7%) |
| Mar 2009 | - | -$85.00 K(-24.1%) | $3.52 M(+4.7%) |
| Dec 2008 | $3.36 M | -$112.00 K(-0.9%) | $3.36 M(+13.4%) |
| Sept 2008 | - | -$113.00 K(-103.0%) | $2.96 M(+25.8%) |
| June 2008 | - | $3.83 M(-1680.6%) | $2.35 M(-205.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$242.00 K(-52.4%) | -$2.24 M(-19.0%) |
| Dec 2007 | -$2.76 M(-105.4%) | -$508.00 K(-29.4%) | -$2.76 M(-108.0%) |
| Sept 2007 | - | -$720.00 K(-6.1%) | $34.73 M(-22.0%) |
| June 2007 | - | -$767.00 K(-0.1%) | $44.54 M(-13.3%) |
| Mar 2007 | - | -$768.00 K(-102.1%) | $51.38 M(+1.1%) |
| Dec 2006 | $50.83 M(+189.4%) | $36.98 M(+306.7%) | $50.83 M(+49.8%) |
| Sept 2006 | - | $9.09 M(+49.6%) | $33.92 M(+40.6%) |
| June 2006 | - | $6.08 M(-561.8%) | $24.14 M(+46.9%) |
| Mar 2006 | - | -$1.32 M(-106.6%) | $16.43 M(-6.4%) |
| Dec 2005 | $17.56 M(+23.8%) | $20.07 M(-2983.8%) | $17.56 M(-939.2%) |
| Sept 2005 | - | -$696.00 K(-57.2%) | -$2.09 M(-51.0%) |
| June 2005 | - | -$1.63 M(+784.2%) | -$4.27 M(-29.5%) |
| Mar 2005 | - | -$184.00 K(-144.4%) | -$6.05 M(-142.7%) |
| Dec 2004 | $14.18 M(+95.9%) | $414.00 K(-114.4%) | $14.18 M(-38.7%) |
| Sept 2004 | - | -$2.87 M(-15.7%) | $23.12 M(-7.6%) |
| June 2004 | - | -$3.41 M(-117.0%) | $25.02 M(-9.9%) |
| Mar 2004 | - | $20.05 M(+114.5%) | $27.77 M(+283.5%) |
| Dec 2003 | $7.24 M(-535.1%) | $9.35 M(-1055.8%) | $7.24 M(-381.6%) |
| Sept 2003 | - | -$978.20 K(+48.7%) | -$2.57 M(+26.6%) |
| June 2003 | - | -$657.70 K(+38.7%) | -$2.03 M(+14.6%) |
| Mar 2003 | - | -$474.30 K(+3.0%) | -$1.77 M(+6.5%) |
| Dec 2002 | -$1.66 M(-1849.7%) | -$460.50 K(+5.2%) | -$1.66 M(+7.0%) |
| Sept 2002 | - | -$437.70 K(+9.8%) | -$1.55 M(+12.1%) |
| June 2002 | - | -$398.80 K(+8.7%) | -$1.39 M(+59.5%) |
| Mar 2002 | - | -$366.90 K(+4.4%) | -$869.30 K(-1014.1%) |
| Dec 2001 | $95.10 K(-99.9%) | -$351.50 K(+30.4%) | $95.10 K(-79.1%) |
| Sept 2001 | - | -$269.50 K(-327.2%) | $455.40 K(-57.8%) |
| June 2001 | - | $118.60 K(-80.2%) | $1.08 M(+7.8%) |
| Mar 2001 | - | $597.50 K(+6689.8%) | $1.00 M(-99.2%) |
| Dec 2000 | $120.00 M(+2690.7%) | $8800.00(-97.5%) | $120.00 M(+0.1%) |
| Sept 2000 | - | $353.70 K(+771.2%) | $119.89 M(+0.4%) |
| June 2000 | - | $40.60 K(-100.0%) | $119.44 M(+0.2%) |
| Mar 2000 | - | $119.60 M(<-9900.0%) | $119.20 M(+2672.0%) |
| Dec 1999 | $4.30 M(+1333.3%) | -$100.00 K(0.0%) | $4.30 M(-2.3%) |
| Sept 1999 | - | -$100.00 K(-50.0%) | $4.40 M(+2.3%) |
| June 1999 | - | -$200.00 K(-104.3%) | $4.30 M(-12.2%) |
| Mar 1999 | - | $4.70 M(>+9900.0%) | $4.90 M(+1533.3%) |
| Dec 1998 | $300.00 K(-92.1%) | $0.00(-100.0%) | $300.00 K(-93.0%) |
| Sept 1998 | - | -$200.00 K(-150.0%) | $4.30 M(-2.3%) |
| June 1998 | - | $400.00 K(+300.0%) | $4.40 M(+12.8%) |
| Mar 1998 | - | $100.00 K(-97.5%) | $3.90 M(+2.6%) |
| Dec 1997 | $3.80 M(+850.0%) | $4.00 M(-4100.0%) | $3.80 M(-1366.7%) |
| Sept 1997 | - | -$100.00 K(0.0%) | -$300.00 K(0.0%) |
| June 1997 | - | -$100.00 K(<-9900.0%) | -$300.00 K(-175.0%) |
| Mar 1997 | - | $0.00(-100.0%) | $400.00 K(0.0%) |
| Dec 1996 | $400.00 K(-98.6%) | -$100.00 K(0.0%) | $400.00 K(0.0%) |
| Sept 1996 | - | -$100.00 K(-116.7%) | $400.00 K(-98.6%) |
| June 1996 | - | $600.00 K(>+9900.0%) | $29.00 M(+2.5%) |
| Mar 1996 | - | $0.00(-100.0%) | $28.30 M(+0.4%) |
| Dec 1995 | $28.20 M(-7150.0%) | -$100.00 K(-100.4%) | $28.20 M(0.0%) |
| Sept 1995 | - | $28.50 M(<-9900.0%) | $28.20 M(-7150.0%) |
| June 1995 | - | -$100.00 K(0.0%) | -$400.00 K(0.0%) |
| Mar 1995 | - | -$100.00 K(0.0%) | -$400.00 K(0.0%) |
| Dec 1994 | -$400.00 K(-101.6%) | -$100.00 K(0.0%) | -$400.00 K(0.0%) |
| Sept 1994 | - | -$100.00 K(0.0%) | -$400.00 K(-102.8%) |
| June 1994 | - | -$100.00 K(0.0%) | $14.50 M(-8.2%) |
| Mar 1994 | - | -$100.00 K(0.0%) | $15.80 M(-36.3%) |
| Dec 1993 | $24.80 M(+169.6%) | -$100.00 K(-100.7%) | $24.80 M(-0.4%) |
| Sept 1993 | - | $14.80 M(+1133.3%) | $24.90 M(+146.5%) |
| June 1993 | - | $1.20 M(-86.5%) | $10.10 M(+13.5%) |
| Mar 1993 | - | $8.90 M | $8.90 M |
| Dec 1992 | $9.20 M(-2400.0%) | - | - |
| Dec 1991 | -$400.00 K(-114.3%) | - | - |
| Dec 1990 | $2.80 M | - | - |
FAQ
- What is Fresh Tracks Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Fresh Tracks Therapeutics?
What is Fresh Tracks Therapeutics annual cash flow from financing activities?
The current annual CFF of FRTX is $6.53 M
What is the all time high annual CFF for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual cash flow from financing activities is $120.00 M
What is Fresh Tracks Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of FRTX is -$28.00 K
What is the all time high quarterly CFF for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly cash flow from financing activities is $119.60 M
What is Fresh Tracks Therapeutics TTM cash flow from financing activities?
The current TTM CFF of FRTX is $6.53 M
What is the all time high TTM CFF for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high TTM cash flow from financing activities is $120.00 M